Cargando…
The Pharmacological and Structural Basis of the AahII–Na(V)1.5 Interaction and Modulation by the Anti-AahII Nb10 Nanobody
Scorpion α-toxins are neurotoxins that target the fast inactivation mechanism of voltage-gated sodium (Na(V)) channels leading to several neuro- and cardiotoxic effects in mammals. The toxin AahII is the most active α-toxin from the North African scorpion Androctonus australis Hector that slows the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918821/ https://www.ncbi.nlm.nih.gov/pubmed/35295326 http://dx.doi.org/10.3389/fphar.2022.821181 |
_version_ | 1784668811257970688 |
---|---|
author | Hmaidi, Riadh Ksouri, Ayoub Benabderrazek, Rahma Antonietti, Viviane Sonnet, Pascal Gautier, Mathieu Bouhaouala-Zahar, Balkiss Ouadid-Ahidouch, Halima |
author_facet | Hmaidi, Riadh Ksouri, Ayoub Benabderrazek, Rahma Antonietti, Viviane Sonnet, Pascal Gautier, Mathieu Bouhaouala-Zahar, Balkiss Ouadid-Ahidouch, Halima |
author_sort | Hmaidi, Riadh |
collection | PubMed |
description | Scorpion α-toxins are neurotoxins that target the fast inactivation mechanism of voltage-gated sodium (Na(V)) channels leading to several neuro- and cardiotoxic effects in mammals. The toxin AahII is the most active α-toxin from the North African scorpion Androctonus australis Hector that slows the fast inactivation of Na(V) channels. To fight scorpion envenomation, an anti-AahII nanobody named NbAahII10 (Nb10) was developed. The efficiency of this nanobody has been evaluated in vivo on mice, but its mechanism of action at the cellular level remains unknown. Here we have shown that AahII toxin slows the fast inactivation of the adult cardiac Na(V)1.5 channels, expressed in HEK293 cells, in a dose-dependent manner, while current amplitude was not affected. The inactivation of Na(V)1.5 is slower by a factor of 4, 7, and 35 in the presence of [AahII] at 75, 150, and 300 nM, respectively. The washout partially reversed the toxin effect on inactivation from 8.3 ± 0.9 ms to 5.2 ± 1.2 ms at 75 nM. We have also demonstrated that the highly neutralizing Nb10 can fully reverse the effect of AahII toxin on the channel inactivation kinetics even at the 1:1 M ratio. However, the 1:0.5 M ratio is not able to neutralize completely the AahII effect. Therefore, the application of Nb10 promotes a partial abolishment of AahII action. Bioinformatic analysis and prediction of Na(V)1.5-driven docking with AahII show that Ala39 and Arg62 of AahII play a crucial role to establish a stable interaction through H-bound interactions with Gln1615 and Lys1616 (S3–S4 extracellular loop) and Asp1553 (S1–S2 loop) from the voltage-sensing domain IV (VSD4) of Na(V)1.5, respectively. From this, we notice that AahII shares the same contact surface with Nb10. This strongly suggests that Nb10 dynamically replaces AahII toxin from its binding site on the Na(V)1.5 channel. At the physiopathological level, Nb10 completely neutralized the enhancement of breast cancer cell invasion induced by AahII. In summary, for the first time, we made an electrophysiological and structural characterization of the neutralization potent of Nb10 against the α-scorpion toxin AahII in a cellular model overexpressing Na(V)1.5 channels. |
format | Online Article Text |
id | pubmed-8918821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89188212022-03-15 The Pharmacological and Structural Basis of the AahII–Na(V)1.5 Interaction and Modulation by the Anti-AahII Nb10 Nanobody Hmaidi, Riadh Ksouri, Ayoub Benabderrazek, Rahma Antonietti, Viviane Sonnet, Pascal Gautier, Mathieu Bouhaouala-Zahar, Balkiss Ouadid-Ahidouch, Halima Front Pharmacol Pharmacology Scorpion α-toxins are neurotoxins that target the fast inactivation mechanism of voltage-gated sodium (Na(V)) channels leading to several neuro- and cardiotoxic effects in mammals. The toxin AahII is the most active α-toxin from the North African scorpion Androctonus australis Hector that slows the fast inactivation of Na(V) channels. To fight scorpion envenomation, an anti-AahII nanobody named NbAahII10 (Nb10) was developed. The efficiency of this nanobody has been evaluated in vivo on mice, but its mechanism of action at the cellular level remains unknown. Here we have shown that AahII toxin slows the fast inactivation of the adult cardiac Na(V)1.5 channels, expressed in HEK293 cells, in a dose-dependent manner, while current amplitude was not affected. The inactivation of Na(V)1.5 is slower by a factor of 4, 7, and 35 in the presence of [AahII] at 75, 150, and 300 nM, respectively. The washout partially reversed the toxin effect on inactivation from 8.3 ± 0.9 ms to 5.2 ± 1.2 ms at 75 nM. We have also demonstrated that the highly neutralizing Nb10 can fully reverse the effect of AahII toxin on the channel inactivation kinetics even at the 1:1 M ratio. However, the 1:0.5 M ratio is not able to neutralize completely the AahII effect. Therefore, the application of Nb10 promotes a partial abolishment of AahII action. Bioinformatic analysis and prediction of Na(V)1.5-driven docking with AahII show that Ala39 and Arg62 of AahII play a crucial role to establish a stable interaction through H-bound interactions with Gln1615 and Lys1616 (S3–S4 extracellular loop) and Asp1553 (S1–S2 loop) from the voltage-sensing domain IV (VSD4) of Na(V)1.5, respectively. From this, we notice that AahII shares the same contact surface with Nb10. This strongly suggests that Nb10 dynamically replaces AahII toxin from its binding site on the Na(V)1.5 channel. At the physiopathological level, Nb10 completely neutralized the enhancement of breast cancer cell invasion induced by AahII. In summary, for the first time, we made an electrophysiological and structural characterization of the neutralization potent of Nb10 against the α-scorpion toxin AahII in a cellular model overexpressing Na(V)1.5 channels. Frontiers Media S.A. 2022-02-28 /pmc/articles/PMC8918821/ /pubmed/35295326 http://dx.doi.org/10.3389/fphar.2022.821181 Text en Copyright © 2022 Hmaidi, Ksouri, Benabderrazek, Antonietti, Sonnet, Gautier, Bouhaouala-Zahar and Ouadid-Ahidouch. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Hmaidi, Riadh Ksouri, Ayoub Benabderrazek, Rahma Antonietti, Viviane Sonnet, Pascal Gautier, Mathieu Bouhaouala-Zahar, Balkiss Ouadid-Ahidouch, Halima The Pharmacological and Structural Basis of the AahII–Na(V)1.5 Interaction and Modulation by the Anti-AahII Nb10 Nanobody |
title | The Pharmacological and Structural Basis of the AahII–Na(V)1.5 Interaction and Modulation by the Anti-AahII Nb10 Nanobody |
title_full | The Pharmacological and Structural Basis of the AahII–Na(V)1.5 Interaction and Modulation by the Anti-AahII Nb10 Nanobody |
title_fullStr | The Pharmacological and Structural Basis of the AahII–Na(V)1.5 Interaction and Modulation by the Anti-AahII Nb10 Nanobody |
title_full_unstemmed | The Pharmacological and Structural Basis of the AahII–Na(V)1.5 Interaction and Modulation by the Anti-AahII Nb10 Nanobody |
title_short | The Pharmacological and Structural Basis of the AahII–Na(V)1.5 Interaction and Modulation by the Anti-AahII Nb10 Nanobody |
title_sort | pharmacological and structural basis of the aahii–na(v)1.5 interaction and modulation by the anti-aahii nb10 nanobody |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918821/ https://www.ncbi.nlm.nih.gov/pubmed/35295326 http://dx.doi.org/10.3389/fphar.2022.821181 |
work_keys_str_mv | AT hmaidiriadh thepharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT ksouriayoub thepharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT benabderrazekrahma thepharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT antoniettiviviane thepharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT sonnetpascal thepharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT gautiermathieu thepharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT bouhaoualazaharbalkiss thepharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT ouadidahidouchhalima thepharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT hmaidiriadh pharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT ksouriayoub pharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT benabderrazekrahma pharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT antoniettiviviane pharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT sonnetpascal pharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT gautiermathieu pharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT bouhaoualazaharbalkiss pharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody AT ouadidahidouchhalima pharmacologicalandstructuralbasisoftheaahiinav15interactionandmodulationbytheantiaahiinb10nanobody |